Stay updated with breaking news from Vivos Integrated Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First Medicare-Accepted Oral Appliance Treatment for All Severities of Obstructive Sleep Apnea in Adults LITTLETON, Colo., April 9, 2024 - Vivos Therapeutics,...
LITTLETON, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device...
Vivos announced it is seeing positive preliminary metrics after receiving FDA clearance for its CARE oral appliances to treat severe OSA.
With this unprecedented FDA clearance, Vivos redefines what it means to have a truly non-invasive treatment for all levels of OSA severity, opening new...
-- Vivos Therapeutics said Wednesday the Food and Drug Administration has granted 510 clearance for its oral device treatment for severe obstructive sleep apnea in adults. The clearance is for its...